PYPD — PolyPid Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1611842 ·
Last close
$4.90
Market Cap
$99.53M
52W High
$5.73
52W Low
$3.06
ADV30
94,597
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -7,849,000 | -7,849,000 | 15,234,000 | 6,563,000 | 9,846,000 |
| Mar 2026 | 0 | — | -7,760,000 | -7,728,000 | 19,160,000 | 8,888,000 | 10,380,000 |
| Dec 2025 | 0 | — | -8,530,000 | -8,473,000 | 22,307,000 | 6,402,000 | 11,334,000 |
| Sep 2025 | 0 | — | -7,455,000 | -7,451,000 | 26,841,000 | 9,669,000 | 11,476,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-309,228,000
Inventory
$1,106,000
Receivables
—
ST Investments
$2,021,000
EBIT TTM
$-33,471,000
Pretax Income TTM
$-33,635,000
Interest Exp TTM
$1,485,000
Analysts
4
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -32,967,000 | -34,169,000 | 22,307,000 | 11,334,000 | 10,973,000 | -27,879,000 |
| Dec 2024 | 0 | -28,029,000 | -29,022,000 | 25,220,000 | 17,536,000 | 7,684,000 | -21,963,000 |
| Dec 2023 | 0 | -22,867,000 | -23,865,000 | 15,372,000 | 17,468,000 | -2,096,000 | -17,236,000 |
| Dec 2022 | 0 | -38,888,000 | -39,557,000 | 25,971,000 | 20,142,000 | 5,829,000 | -34,317,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.23
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $4.90 · call volume: 11 · put volume: 147
Expected Move to 2026-10-16:
±$1.08
(22.04%) —
implied range
$3.82 –
$5.98
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| APYX | Apyx Medical Corp | $99.41M | $2.36 | — |
| LAKE | LAKELAND INDUSTRIES INC | $100.21M | $10.09 | — |
| CNXU | Conexeu Sciences Inc. | $97.31M | $3.45 | — |
| QTEX | QTREX Quantum Ltd. | $94.15M | $1.69 | — |
| VANI | Vivani Medical, Inc. | $110.95M | $1.23 | — |
News headlines (Yahoo Finance, 1h cache)
PolyPid Nears FDA Decision for D-PLEX100 After Strong Phase III Data
2026-10-04 22:02 · Yahoo
PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
2026-10-01 12:56 · Yahoo
PolyPid Announces Participation in Upcoming Fall Investor Conferences
2026-09-15 12:30 · Yahoo
PolyPid (PYPD) Q2 2026 Earnings Call Transcript
2026-08-19 15:27 · Yahoo
PolyPid Ltd (PYPD) (Q2 2026) Earnings Call Highlights: FDA Priority Review and $30M Azurity ...
2026-08-12 23:03 · Yahoo
PolyPid Ltd. Q2 2026 Earnings Call Summary
2026-08-12 21:07 · Yahoo
PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026
2026-07-30 12:00 · Yahoo
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
2026-07-29 12:30 · Yahoo
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid
2026-07-21 13:15 · Yahoo
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
2026-07-21 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.